晚期肝病患者运动干预结局:随机临床试验的系统综述
本系统综述纳入11项随机临床试验共358例晚期肝病患者,干预时长8至14周,包括骑行、步行、抗阻、平衡协调及呼吸训练。结果显示运动干预可改善肌肉适能和心肺适能及生活质量,在肝硬化患者中似乎安全且耐受良好。
要点
- 11项随机临床试验共358例晚期肝病患者,运动干预时长8至14周。
- 9项研究至少1项体能指标显著改善,10项研究至少1项肌肉适能指标显著改善。
- 6项研究至少1项生活质量指标显著改善,报告数据的9项研究中干预组未见门静脉高压并发症。
核心结论
- 对11项随机临床试验共358例晚期肝病患者的综述表明,运动干预可在肌肉适能、心肺适能和生活质量方面产生有利结局。
- 尽管失访率和依从性各异,这些干预在肝硬化患者中似乎安全且耐受良好。
研究设计与样本
- 系统综述,由两名作者独立检索PubMed和EMBASE从建库至2021年11月18日的随机临床试验,第三名独立仲裁者裁决所有分歧。
- 共纳入11项随机临床试验(其中4项为家庭为基础干预),358例参与者。
主要发现
- 干预时长8至14周,包括骑行、步行、抗阻训练、平衡与协调训练及呼吸训练。
- 9项研究显示至少1项体能变量有统计学显著改善。
- 10项研究显示至少1项肌肉适能变量有统计学显著改善。
- 6项研究显示至少1项生活质量变量有统计学显著改善。
- 失访率为5%至36%,依从率范围很宽为14%至100%;仅1项研究报告衰弱指数;报告数据的9项研究中干预组未见门静脉高压并发症。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 失访率为5%至36%,依从率范围很宽为14%至100%。
- 仅1项研究报告衰弱指数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Frailty and sarcopenia are common complications of advanced liver disease. Owing to associated morbidity/mortality, there have been targeted efforts to prevent and/or improve both by enrolling these patients in focused exercise programs. This review systematically analyzes the data of randomized clinical trials (RCTs) on anthropometric, physical fitness, quality-of-life, and safety outcomes of exercise interventions in patients with advanced liver disease. METHODS: Two authors independently searched trials on PubMed and EMBASE from inception up to November 18, 2021. A third independent arbitrator adjudicated all disagreements. We qualitatively summarized these outcomes as follows: (i) muscular fitness (maximal inspiratory/expiratory pressures, muscle size, muscle strength, and bioimpedance testing), (ii) cardiorespiratory fitness (cardiopulmonary exercise testing and 6-minute walk distance), (iii) quality of life, and (iv) others (safety or frailty indices). RESULTS: There were 11 RCTs (4 home-based interventions) with 358 participants. Interventions ranged from 8 to 14 weeks and included cycling, walking, resistance exercises, balance and coordination training, and respiratory exercises. All described outcomes compared preintervention with postintervention measurements. Nine studies showed statistically significant improvements in at least 1 physical fitness variable. Ten studies showed statistically significant improvements in at least 1 muscular fitness variable. Six studies showed statistically significant improvements in at least 1 quality-of-life variable. Attrition rates ranged from 5% to 36%, and adherence rates ranged very widely from 14% to 100%. Only 1 study reported frailty indices. Notably, no complications of portal hypertension were seen in intervention groups in the 9 studies that reported these data. DISCUSSION: A review of 11 RCTs with 358 participants with advanced liver disease demonstrates that exercise interventions can have favorable outcomes on muscular/cardiorespiratory fitness and quality of life. Although attrition and adherence varied, these interventions seem to be safe in patients with cirrhosis and are well tolerated.
引用
- Jamali T, Raasikh T, Bustamante G, et al. Outcomes of Exercise Interventions in Patients With Advanced Liver Disease: A Systematic Review of Randomized Clinical Trials. Am J Gastroenterol. 2022. PMID: 35973182. doi:10.14309/ajg.0000000000001883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。